Cargando…
Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
Circulating tumor DNA (ctDNA) isolated from peripheral blood has recently been shown to be an alternative source to detect gene mutations in primary tumors; however, most previous studies have focused on advanced stage cancers, and few have evaluated ctDNA detection in early-stage lung cancer. In th...
Autores principales: | Chen, Ke-Zhong, Lou, Feng, Yang, Fan, Zhang, Jing-Bo, Ye, Hua, Chen, Wei, Guan, Tian, Zhao, Ming-Yu, Su, Xue-Xia, Shi, Rong, Jones, Lindsey, Huang, Xue F., Chen, Si-Yi, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995492/ https://www.ncbi.nlm.nih.gov/pubmed/27555497 http://dx.doi.org/10.1038/srep31985 |
Ejemplares similares
-
Circulating tumor DNA detection in lung cancer patients before and after surgery
por: Guo, Nannan, et al.
Publicado: (2016) -
Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018) -
Role of circulating tumor DNA in the management of early‐stage lung cancer
por: Zhao, Heng, et al.
Publicado: (2018) -
Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022) -
Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
por: Duan, Guo-Chen, et al.
Publicado: (2020)